An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis
- DOI
- 10.1159/000552115
- Published
- 2026-04-24
- Container
- Liver Cancer
- Publisher
- S. Karger AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1159/000552115,
title = {An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis},
author = {Markus Peck-Radosavljevic and Akhmed Abdelgafur and Alessandro Granito and Antonio Gasbarrini and Yuk Ting Ma and Edward Mena and José Luis Lledó-Navarro and José Presa and Arndt Weinmann and Miriam T. Levy and Adriano Pellicelli and Dirk-Thomas Waldschmidt and Henrik Toft Sørensen and Lipika Goyal and Min Ren and Hakim Saal and Chinyere E. Okpara and Tim Meyer},
year = {2026},
journal = {Liver Cancer},
doi = {10.1159/000552115},
url = {https://doi.org/10.1159/000552115}
}RIS
TY - JOUR TI - An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis AU - Markus Peck-Radosavljevic AU - Akhmed Abdelgafur AU - Alessandro Granito AU - Antonio Gasbarrini AU - Yuk Ting Ma AU - Edward Mena AU - José Luis Lledó-Navarro AU - José Presa AU - Arndt Weinmann AU - Miriam T. Levy AU - Adriano Pellicelli AU - Dirk-Thomas Waldschmidt AU - Henrik Toft Sørensen AU - Lipika Goyal AU - Min Ren AU - Hakim Saal AU - Chinyere E. Okpara AU - Tim Meyer PY - 2026 JO - Liver Cancer DO - 10.1159/000552115 UR - https://doi.org/10.1159/000552115 ER -
APA
Peck-Radosavljevic, M., Abdelgafur, A., Granito, A., Gasbarrini, A., Ma, Y. T., Mena, E., Lledó-Navarro, J. L., Presa, J., Weinmann, A., Levy, M. T., Pellicelli, A., Waldschmidt, D., Sørensen, H. T., Goyal, L., Ren, M., Saal, H., Okpara, C. E., & Meyer, T. (2026). An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis. Liver Cancer. https://doi.org/10.1159/000552115
Source records
- crossref · retrieved 2026-09-26T14:03:29.060Z